Rise of the Resistance: Challenging Carbapenem-Resistant Gram-Negative Infections

Hear from experts on strategies to optimize treatment regimens for carbapenem-resistant Enterobacterales, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia based on the latest guidance recommendations, clinical data, and patient-specific and infection-related factors. Reinforce your learning with an on-demand video, downloadable slides, and an expert-authored ClinicalThought commentary.

Share

Program Content

Activities

Treating P. aeruginosa With Difficult to Treat Resistance
Where Are We Now? A Decade of Using Newer β-lactams to Treat Pseudomonas aeruginosa With Difficult-to-Treat Resistance
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 25, 2024

Expires: September 24, 2025

Activities

Resistant Gram-Negative Infections
Rise of the Resistance: Challenging Carbapenem-Resistant Gram-Negative Infections
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 11, 2024

Expires: October 10, 2025

Activities

Managing Carbapenem-Resistant Gram-Negative infection
Rise of the Resistance: Challenging Carbapenem-Resistant Gram-Negative Infections
Video
Congratulations: You achieved a completion on 04/09/2022

Released: November 04, 2024

Expires: November 03, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Shionogi Pharma, Inc.

Shionogi Pharma, Inc.